January 28, 2020
By Sharon Rosen
Patients suffering from depression, anxiety and substance use disorders often search for years to find treatment. Studies have shown that during this time gap, patients’ symptoms worsen, increasing their risk for other chronic illnesses, shortened lifespan and poor quality of life. Mayo Clinic statistical geneticist Joanna Biernacka, Ph.D. and her colleagues are working to change […]
Tags: #Mayo Clinic Biobank, anxiety, center for individualized medicine, depression, Genetic Testing, genomics, Joanna Biernacka, mayo clinic, Project Generation, psychiatric disorders, risk score, substance abuse disorder